Business ❯ Market Competition

Pharmaceutical Companies

Eli Lilly Novo Nordisk GSK Acadia Pharmaceuticals Eli Lilly vs Novo Nordisk Sun Pharmaceuticals AstraZeneca Sales Performance

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Pfizer plans 10 phase 3 trials this year to test higher monthly doses suggested by the phase 2 data.

Medicare GLP-1 Use Surges as CMS Advances Coverage Expansion and Lilly Eyes Q2 Pill Launch

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Lilly to Launch Late-Stage Trials of Amylin Obesity Drug After 20% Weight Loss in Mid-Stage Study

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Acadia Halts Carbetocin for Prader-Willi After Phase 3 Miss